Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Bupivacaine/Dexamethasone for Shoulder Arthroscopy Recovery
NCT04461028Phase 3Withdrawn
- Sponsor
- University of Pennsylvania
- Start
- Feb 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in rotator cuff tear, sponsored by University of Pennsylvania. Planned start Feb 2019; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT04461028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461028.